
This study explored whether laryngeal carcinoma could be divided into subtypes based on molecular differences using a molecular subtype‐prediction model. The study categorized 126 patients into C1 and C2 molecular subtypes associated with pathologic grade. Laryngeal carcinoma can be divided into two subtypes based on differences in molecular expression, which could identify critical molecules related to prognosis.
Like
Save
Share